AtriCure
ATRC
105 hedge funds and large institutions have $498M invested in AtriCure in 2014 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 33 increasing their positions, 41 reducing their positions, and 14 closing their positions.
42% more capital invested
Capital invested by funds: $351M → $498M (+$148M)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
6% less funds holding
Funds holding: 112 → 105 (-7)
20% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 41
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$6.75M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$5.51M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.79M |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$4M |
| 5 |
RIM
RS Investment Management
San Francisco,
California
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
Castleark Management
Chicago,
Illinois
|
-$10.7M |
| 2 |
GTC
Ghost Tree Capital
New York
|
-$2.57M |
| 3 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$2.57M |
| 4 |
BC
Broadfin Capital
New York
|
-$1.72M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$1.46M |
ATRC Hedge Fund Activity: Q4 2014 in Review
105 of the 3,765 institutional investors tracked by Wall St. Rank reported a position in AtriCure (ATRC) for Q4 2014, worth a combined $498M — up 42% from $351M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of ATRC and 10 opened new positions — a net loss of 4 holders — while 41 trimmed existing stakes and 33 added.
The largest buyer was Millennium Management, adding an estimated $6.75M. The largest seller was Castleark Management, exiting entirely with an estimated $10.7M sold.
- 105 institutional investors held AtriCure (ATRC) as of Q4 2014, down from 112 in Q3 2014.
- Funds reported $498M of AtriCure stock for Q4 2014, up 42% quarter-over-quarter.
- 10 funds opened new AtriCure positions in Q4 2014 and 14 closed out, a net change of -4 holders.
- The largest AtriCure buyer in Q4 2014 was Millennium Management, an estimated $6.75M added.
- The largest AtriCure seller in Q4 2014 was Castleark Management, an estimated $10.7M sold.
Based on aggregated 13F filings for Q4 2014.